The Prognosis For Pfizer [Seeking Alpha]
Pfizer, Inc. (PFE)
Last pfizer, inc. earnings: 4/28 06:45 am
Check Earnings Report
US:NYSE Investor Relations:
investors.pfizer.com/investors-overview/default.aspx
Company Research
Source: Seeking Alpha
The acquisition of Seagen did add blockbuster oncology therapies to Pfizer's portfolio, boosting sagging oncology sales. Pfizer plans to launch new therapies and expand its oncology pipeline, aiming to generate $45 billion in revenue by 2030. With a low P/E compared to the overall market and a near six percent dividend yield, Pfizer merited a deeper dive. An analysis of the drug behemoth follows in the paragraphs below. Not really needing any introduction, Pfizer Inc. ( NYSE: PFE is a New York City-based biopharmaceutical behemoth that generated revenues of more than $240 billion in 2021-2023, primarily from vaccines and cancer medicines, which are sold in more than 200 countries across the planet. The Recommended For You Recommended For You About PFE Stock
Show less
Read more
Impact Snapshot
Event Time:
PFE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
PFE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
PFE alerts
High impacting Pfizer, Inc. news events
Weekly update
A roundup of the hottest topics
PFE
News
- Pentagon ran secret anti-vaccine campaign to undermine China during COVID-19 pandemic, investigation finds [Globe and Mail, The (Toronto, Canada)]Globe and Mail, The
- Pharma Stock Roundup: FDA Panel Endorses LLY's Donanemab, PFE's DMD Therapy Study Fails [Yahoo! Finance]Yahoo! Finance
- Is It Too Late to Buy Pfizer Stock? [Yahoo! Finance]Yahoo! Finance
- ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple Myeloma [Yahoo! Finance]Yahoo! Finance
- ELREXFIO™ Shows Median Overall Survival of More Than Two Years in People with Relapsed or Refractory Multiple MyelomaBusiness Wire
PFE
Earnings
- 5/1/24 - Beat
PFE
Sec Filings
- 6/11/24 - Form 11-K
- 6/11/24 - Form 11-K
- 6/4/24 - Form 4
- PFE's page on the SEC website